Developing a Mobile App for Patients With Hypertension

NCT07556419 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2026-04-29

No results posted yet for this study

Summary

This project, based on King's Goal Achievement Theory, aims to develop a mobile application for individuals over 18 years of age diagnosed with hypertension. The project comprises the stages of educational content creation, mobile application design, implementation, and effectiveness evaluation. Within the scope of the project, individuals' blood pressure control, self-efficacy levels, and treatment adherence behaviors will be assessed using valid and reliable measurement tools, and the goal is to support these behaviors through the developed mobile health application. Participants' clinical treatment processes, pharmacological treatment adjustments planned by the physician, and medication dosage changes will be excluded from the project scope. No intervention will be made to the currently applied medical treatment during the study; participants' routine clinical follow-up and treatment processes will continue within the framework of standard care. Only education and mobile application-based supportive interventions will be implemented within the scope of the project.

Conditions

  • Hypertension
  • Mobile Application
  • Blood Pressure Control
  • Treatment Adherence
  • Self-Efficacy

Interventions

BEHAVIORAL

Mobile application

The mobile application will be developed for patients with hypertension. It will include educational videos, educational texts, and reminders.

BEHAVIORAL

control group

The control group will not be interfered with.

Sponsors & Collaborators

  • Kafkas University

    lead OTHER

Principal Investigators

  • Rabia B Bayrambey, 1 · Kafkas University

  • Yeliz A Akkuş, 2 · Nigde Omer Halisdemir University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-02
Primary Completion
2026-09-30
Completion
2027-03-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07556419 on ClinicalTrials.gov